Drug:
Reaction: DYSPNOEA
20250101 - 20251231
No. 101 - 200
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
101 | 25132315 |
US |
1 | |
Oxygen saturation decreased, Dyspnoea, Fatigue, Cough, Blood pressure systolic decreased, Chest pain, Discomfort, Oedema peripheral, Condition aggravated, Oedema, Chest discomfort, Diarrhoea, Oropharyngeal pain, Dysphagia, Dysphonia, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, NINTEDANIB, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PREDNISONE, INSULIN LISPRO, NIFEDIPINE, TIZANIDINE HYDROCHLORIDE, INSULIN GLARGINE, ALBUTEROL SULFATE, SERTRALINE HYDROCHLORIDE, GABAPENTIN, APIXABAN, ISOSORBIDE MONONITRATE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, SPIRONOLACTONE, OXYGEN, 0XYGEN, SIMVASTATIN, FUROSEMIDE, MINOXIDIL, OIL, VITAMIN C, |
||||
102 | 25132316 |
GB |
||
Cardiac arrest, Coma, Pain, Pyrexia, Condition aggravated, Dyspnoea, Swelling, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
103 | 25132329 |
US |
2 | |
Dyspnoea, |
||||
TREPROSTINIL, TREPROSTINIL, LOPERAMIDE HYDROCHLORIDE, SUCROFERRIC OXYHYDROXIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, MACITENTAN, PANTOPRAZOLE SODIUM, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, OXYGEN, 0XYGEN, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, DIGOXIN, ACETAMINOPHEN, WARFARIN SODIUM, WARFARIN, BUPRENORPHINE, |
||||
104 | 25132370 |
US |
1 | |
Cough, Productive cough, Dyspnoea exertional, Dizziness, Diarrhoea, Asthenia, Decreased appetite, Flushing, Headache, Dyspnoea, Bronchospasm, Fatigue, Therapy non-responder, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, LANSOPRAZOLE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, RIVAROXABAN, ROSUVASTATIN CALCIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE, OXYGEN, 0XYGEN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ESCITALOPRAM OXALATE, ESCITALOPRAM, BENZONATATE, FAMOTIDINE, |
||||
105 | 25132520 |
US |
||
Chronic obstructive pulmonary disease, Dyspnoea, Cardiac failure congestive, Asthenia, Product use issue, Device use issue, Incorrect dose administered, Device malfunction, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
106 | 25132570 |
US |
54 | 1 |
Dyspnoea, Chest pain, Asthenia, Feeling cold, Cardiac disorder, Headache, |
||||
DUPILUMAB, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, MONTELUKAST SODIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FEXOFENADINE HYDROCHLORIDE, FLUTICASONE PROPIONATE, ALBUTEROL SULFATE, OXYGEN, 0XYGEN, |
||||
107 | 25132638 |
2 | ||
Dyspnoea, Chest pain, Throat tightness, Musculoskeletal stiffness, Tremor, Blood pressure increased, |
||||
DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE, |
||||
108 | 25132729 |
CA |
75 | 2 |
Arterial stenosis, Blood uric acid increased, Dyspepsia, Dysphagia, Dyspnoea exertional, Heart valve incompetence, Osteoarthritis, Pain in extremity, Product dose omission issue, Product supply issue, Dyspnoea, Fatigue, Chest pain, Myalgia, |
||||
MAVACAMTEN, MAVACAMTEN, OIL, BIOTIN, HAIR, EZETIMIBE, FOLIC ACID, MAGNESIUM, MELATONIN, METHOTREXATE, METHOTREXATE SODIUM, METOPROLOL TARTRATE, METOPROLOL, SPIRONOLACTONE, LEVOTHYROXINE SODIUM, TELMISARTAN, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
109 | 25132765 |
HU |
||
Dyspnoea, Osteosclerosis, Back pain, Pneumonia, |
||||
PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF, |
||||
110 | 25132771 |
ES |
45 | 1 |
Dyspnoea, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
111 | 25132821 |
US |
64 | |
Dyspnoea, Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
112 | 25132939 |
GB |
71 | 1 |
Blindness, Myocardial infarction, Abdominal discomfort, Malaise, Headache, Nausea, Diarrhoea, Hallucination, Malaise, COVID-19, Dizziness, Tinnitus, Arthralgia, Pain of skin, Peripheral swelling, Disturbance in attention, Cognitive disorder, Memory impairment, Visual impairment, Diplopia, Sleep terror, Transient ischaemic attack, Fatigue, Vomiting, Pericarditis, Cardiospasm, Dyspnoea, Atrial tachycardia, Anxiety, Muscular weakness, Feeling abnormal, Insomnia, Subarachnoid haemorrhage, Heart rate increased, Muscle twitching, Abdominal pain upper, Dehydration, Hyperhidrosis, Rash papular, Lip swelling, Pruritus, Palmoplantar keratoderma, Dry skin, Angioedema, Chest pain, Palpitations, Tachycardia, Off label use, Intentional product misuse, Pain, Anosmia, Eye pruritus, Facial pain, Abdominal discomfort, Carotid artery occlusion, Back pain, Adverse drug reaction, Abdominal pain upper, Blood glucose increased, Amnesia, Immunisation, Alopecia, Pyrexia, Tension headache, Migraine, Vasculitis, Intentional product use issue, Pruritus genital, Ventricular tachycardia, |
||||
BISOPROLOL FUMARATE, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, HYDROCHLOROTHIAZIDE, ISOSORBIDE DINITRATE, ISOSORBIDE MONONITRATE, LANSOPRAZOLE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LINAGLIPTIN, NAPROXEN, NAPROXEN SODIUM, SIMVASTATIN, APIXABAN, AMITRIPTYLINE HYDROCHLORIDE, LOSARTAN POTASSIUM, LOSARTAN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CANDESARTAN, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, DAPAGLIFLOZIN, DIGOXIN, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, SIMVASTATIN, LANSOPRAZOLE, BISOPROLOL FUMARATE, |
||||
113 | 25132949 |
US |
||
Dyspnoea, Dizziness, Lip swelling, Infusion related reaction, Off label use, |
||||
INFLIXIMAB, |
||||
114 | 25132958 |
CN |
63 | 2 |
Flushing, Chest discomfort, Dyspnoea, |
||||
PERTUZUMAB, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
115 | 25132982 |
US |
1 | |
Dyspnoea, Respiratory tract infection, Rash, |
||||
116 | 25133070 |
US |
2 | |
Dyspnoea, Fluid retention, Loss of consciousness, Illness, Cough, Fatigue, Headache, Constipation, |
||||
TREPROSTINIL, TREPROSTINIL, NINTEDANIB, NINTEDANIB, NINTEDANIB, NINTEDANIB, NINTEDANIB, |
||||
117 | 25133301 |
US |
||
Dyspnoea, Retching, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
118 | 25133303 |
US |
73 | |
Dyspnoea, Lip and/or oral cavity cancer, Pneumonia, Dysphagia, Body height decreased, Sensation of foreign body, Product use in unapproved indication, Off label use, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, PREDNISONE, |
||||
119 | 25133343 |
US |
70 | 1 |
Urticaria, Pruritus, Urticaria, Flushing, Erythema, Dyspnoea, |
||||
ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, METHYLPREDNISOLONE SODIUM SUCCINATE, TIRZEPATIDE, DAPAGLIFLOZIN, ERGOCALCIFEROL, IRBESARTAN, ACETYLCYSTEINE, ALBUTEROL SULFATE, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, MOMETASONE FUROATE, MOMETASONE, VITAMIN C, ERGOCALCIFEROL, FISH OIL, OIL, BIOTIN, HAIR, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, MAGNESIUM HYDROXIDE, TURMERIC, SOAP, OIL, CALCIUM CARBONATE, KETOCONAZOLE, KENALOG, SILDENAFIL CITRATE, SILVER SULFADIAZINE, |
||||
120 | 25133361 |
CA |
10 | 2 |
Cough, Dyspnoea, Angioedema, Erythema, Abdominal discomfort, Arthritis, Incorrect drug administration rate, Off label use, |
||||
INFLIXIMAB, MESALAMINE, PREDNISONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
121 | 25133394 |
US |
18 | 2 |
Chest discomfort, Dyspnoea, |
||||
DUPILUMAB, |
||||
122 | 25133440 |
PL |
47 | 2 |
Dyspnoea, Feeling hot, Nausea, Blood pressure decreased, Hyperhidrosis, Altered state of consciousness, |
||||
CARBOPLATIN, |
||||
123 | 25133451 |
US |
47 | 1 |
Dyspnoea, Eye pruritus, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
124 | 25133465 |
US |
63 | 2 |
Loss of personal independence in daily activities, Dyspnoea, |
||||
DUPILUMAB, |
||||
125 | 25133527 |
ES |
||
Thrombocytopenia, Neutropenia, Leukopenia, Neuropathy peripheral, Unevaluable event, Insomnia, Off label use, Stress, Anxiety, Cough, Dyspnoea, Weight decreased, Anaemia, Chest pain, Fatigue, Nausea, Decreased appetite, Constipation, Vomiting, Ageusia, Alopecia, Mucosal inflammation, Oral pain, Depression, Dry skin, Dry mouth, Diarrhoea, Pyrexia, Influenza like illness, Myalgia, Rash, Arthralgia, Dyspnoea, Fluid retention, Abdominal pain, Headache, Mood altered, Infection, |
||||
DENOSUMAB, BEVACIZUMAB, |
||||
126 | 25133551 |
CA |
||
White blood cell count increased, Rheumatic fever, X-ray abnormal, Lung disorder, Laryngitis, Grip strength, Pneumonia, Visual impairment, Stomatitis, Weight increased, Joint range of motion decreased, Bone erosion, Irritable bowel syndrome, Lupus-like syndrome, Systemic lupus erythematosus, Muscle injury, Impaired healing, Dyspnoea, Hepatic enzyme increased, Abdominal pain upper, Headache, Oedema, Loss of personal independence in daily activities, Dizziness, Night sweats, Weight fluctuation, Swollen joint count increased, Pancreatitis, Rectal haemorrhage, Rheumatoid arthritis, Decreased appetite, Obesity, Laboratory test abnormal, Weight decreased, Diarrhoea, Gait disturbance, Glossodynia, Hand deformity, Exostosis, Mobility decreased, Liver disorder, Musculoskeletal stiffness, Sciatica, General physical health deterioration, Adjustment disorder with depressed mood, Depression, Arthritis, Facet joint syndrome, Insomnia, Lip dry, Vomiting, Discomfort, Hepatic cirrhosis, Folliculitis, Inflammation, Pyrexia, Liver injury, Autoimmune disorder, Anti-cyclic citrullinated peptide antibody positive, Peripheral swelling, Oedema peripheral, Pain, Fibromyalgia, Wound, Hypoaesthesia, Condition aggravated, Gastrointestinal disorder, Nasopharyngitis, Feeling hot, Memory impairment, Delirium, Swollen joint count, Breast cancer stage III, Asthma, Porphyria acute, Paraesthesia, Foot deformity, Wheezing, Synovitis, Ill-defined disorder, Arthralgia, Dry mouth, Crohn^s disease, Muscle spasms, Muscular weakness, Rash, Chest pain, Contusion, Infusion related reaction, Peripheral venous disease, Rheumatoid factor positive, Duodenal ulcer perforation, Migraine, Abdominal discomfort, Hypertension, Osteoarthritis, Sinusitis, Pruritus, Grip strength decreased, Asthenia, Type 2 diabetes mellitus, Fatigue, Musculoskeletal pain, Sleep disorder due to general medical condition, insomnia type, Pemphigus, Sleep disorder due to a general medical condition, Abdominal pain, Pulmonary fibrosis, C-reactive protein abnormal, Blood cholesterol increased, Hypersensitivity, Nausea, Joint swelling, Arthropathy, Swelling, Blister, Walking aid user, Drug hypersensitivity, Amnesia, Retinitis, Bursitis, Osteoporosis, Anxiety, Dyspepsia, Frequent bowel movements, Urticaria, Hypercholesterolaemia, Injury, Colitis ulcerative, Psoriatic arthropathy, Malaise, Lupus vulgaris, Confusional state, Dislocation of vertebra, Road traffic accident, Alopecia, Pericarditis, Infection, Ear infection, Lower respiratory tract infection, Wound infection, Helicobacter infection, Maternal exposure during pregnancy, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, SECUKINUMAB, SECUKINUMAB, RAMIPRIL, LISINOPRIL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, ERYTHROMYCIN, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, ALBUTEROL SULFATE, ALBUTEROL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, HYDROXYCHLOROQUINE SULFATE, LANSOPRAZOLE, ERGOCALCIFEROL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, TOCILIZUMAB, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, APREMILAST, APREMILAST, APREMILAST, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LORAZEPAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, PREGABALIN, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, PREGABALIN, HYALURONIDASE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, LEFLUNOMIDE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, DESOXIMETASONE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, LORAZEPAM, FLUOROMETHOLONE, SULFASALAZINE, SULFASALAZINE, QUETIAPINE FUMARATE, QUETIAPINE, APREPITANT, FOSAPREPITANT DIMEGLUMINE, MESALAMINE, TOFACITINIB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LISINOPRIL, RITUXIMAB, RITUXIMAB, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, CAFFEINE, MELOXICAM, MORPHINE, MAGNESIUM, USTEKINUMAB, TOFACITINIB, TOFACITINIB, DOXYCYCLINE, DOXYCYCLINE HYCLATE, LANSOPRAZOLE, INFLIXIMAB, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, CALCIUM CARBONATE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, HYDROXYCHLOROQUINE SULFATE, SECUKINUMAB, |
||||
127 | 25133554 |
IN |
||
Dyspnoea, |
||||
OSIMERTINIB, |
||||
128 | 25133659 |
40 | 2 | |
Psychotic disorder, Hunger, Feeling abnormal, Fatigue, Agoraphobia, Thinking abnormal, Somnolence, Dyspnoea, Anxiety, Panic attack, Product dose omission issue, Insurance issue, Therapy interrupted, |
||||
SOLRIAMFETOL, SOLRIAMFETOL, SODIUM OXYBATE, SODIUM OXYBATE, SODIUM OXYBATE, |
||||
129 | 25133757 |
CA |
62 | 2 |
Dyspnoea, Lung consolidation, Oxygen therapy, Pneumonitis, Pyrexia, |
||||
DAPTOMYCIN, DAPTOMYCIN, ALLOPURINOL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BETAMETHASONE VALERATE, BETAMETHASONE VALERATE FOAM, CANDESARTAN, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, COLCHICINE, FISH OIL, FUROSEMIDE, EMPAGLIFLOZIN, IVABRADINE, LANSOPRAZOLE, METOPROLOL TARTRATE, METOPROLOL, SEMAGLUTIDE, ROSUVASTATIN, ALBUTEROL SULFATE, ALBUTEROL, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, INSULIN DEGLUDEC, INSULIN ASPART, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
130 | 25133801 |
IN |
57 | |
Rash, Dyspnoea, Hyperhidrosis, Dizziness, Hypersensitivity, |
||||
TREMELIMUMAB, |
||||
131 | 25133887 |
CA |
57 | 1 |
Wheezing, Dysarthria, Infusion related reaction, Blood pressure increased, Sputum abnormal, Erythema, Endotracheal intubation, Cough, Pain, Chest discomfort, Flushing, Oxygen therapy, Dyspnoea, |
||||
ETOPOSIDE, CARBOPLATIN, BUPROPION HYDROCHLORIDE, BUPROPION, ALBUTEROL SULFATE, ALBUTEROL, RAMIPRIL, ROSUVASTATIN, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, NETUPITANT AND PALONOSETRON, FOSNETUPITANT AND PALONOSETRON, FUROSEMIDE, SERTRALINE, DAPAGLIFLOZIN, |
||||
132 | 25133903 |
US |
2 | |
Dyspnoea, Product use in unapproved indication, |
||||
DUPILUMAB, ALBUTEROL SULFATE, FOLIC ACID, MELOXICAM, METHOTREXATE, METHOTREXATE SODIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, MONTELUKAST SODIUM, TOCILIZUMAB, TIRZEPATIDE, |
||||
133 | 25134007 |
US |
1 | |
Dyspnoea, Product prescribing error, Drug ineffective, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
134 | 25134042 |
US |
54 | 2 |
Dyspnoea, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL, |
||||
135 | 25134137 |
US |
2 | |
Pneumonia, Cough, Rhonchi, Insomnia, Dyspnoea, |
||||
CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, ALBUTEROL SULFATE, ARMODAFINIL, AZELASTINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, MELATONIN, MONTELUKAST, SPIRONOLACTONE, SPIRONOLACTONE, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, TRETINOIN, |
||||
136 | 25134144 |
US |
2 | |
Dyspnoea, Wrong technique in device usage process, Extra dose administered, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
137 | 25134181 |
US |
73 | 2 |
Muscular weakness, Insomnia, Cough, Dyspnoea, Sensitivity to weather change, Sinus disorder, Epistaxis, Product use complaint, Device malfunction, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, BENZETHONIUM CHLORIDE 0.13%, LEVOTHYROXINE, TADALAFIL, OXYGEN, 0XYGEN, COLCHICINE, SPIRONOLACTONE, FUROSEMIDE, BOSENTAN, LOVASTATIN, |
||||
138 | 25134260 |
IT |
39 | 2 |
Throat tightness, Dyspnoea, |
||||
OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, BUPIVACAINE, BUPIVACAINE HYDROCHLORIDE IN DEXTROSE, |
||||
139 | 25134287 |
GB |
88 | 2 |
Hepatitis, Hepatic cirrhosis, Hepatotoxicity, Acute kidney injury, Nausea, Decreased appetite, Dyspnoea, Dyspepsia, Abdominal distension, Carbohydrate antigen 125 increased, Condition aggravated, |
||||
METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, OXYCODONE, WATER, ACONITUM NAP, ARSENICUM ALB, BORAX, CALC PHOS, GELSENIUM, LYCOPODIUM, PHOSPHORICUM AC, PICRICUM AC, PLUMB MET, SOLIDAGO, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BECLOMETHASONE DIPROPIONATE, TEMAZEPAM, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, LOSARTAN, ISOSORBIDE DINITRATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, NITROGLYCERIN, METHYLPREDNISOLONE ACETATE, CLOTRIMAZOLE, DRS. CLOTRIMAZOLE, FAMILY WELLNESS CLOTRIMAZOLE, CLOTRIMAZOLE TOPICAL, CHLORPHENIRAMINE MALEATE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE, FUROSEMIDE, |
||||
140 | 25134399 |
US |
||
Dyspnoea, Pneumonitis, |
||||
DURVALUMAB, |
||||
141 | 25134412 |
PL |
1 | |
Dyspnoea, |
||||
KIT FOR THE PREPARATION OF GALLIUM GA 68 GOZETOTIDE, |
||||
142 | 25134420 |
US |
82 | 2 |
Dyspnoea, Oropharyngeal pain, Product complaint, |
||||
UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ACETYLCHOLINE CHLORIDE, ACETYLCHOLINE CHLORIDE, HELICOBACTER PYLORI DNA, ACETYLCHOLINE CHLORIDE,, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, |
||||
143 | 25134466 |
US |
71 | 1 |
Dyspnoea, Taste disorder, Drug ineffective, Product complaint, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
144 | 25134506 |
US |
2 | |
Condition aggravated, Hemiparesis, Pain, Chills, Depressed mood, Pyrexia, Dry throat, Dyspnoea, Malaise, Urinary tract infection, Central nervous system lesion, Insomnia, |
||||
OFATUMUMAB, |
||||
145 | 25134516 |
US |
1 | |
Duchenne muscular dystrophy, Disease progression, Coma, Cardio-respiratory arrest, Brain oedema, Heart rate irregular, Dyspnoea, |
||||
VAMOROLONE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, HYDROXYZINE, HYDROXYZINE, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, SACUBITRIL AND VALSARTAN, |
||||
146 | 25134642 |
US |
||
Obstructive airways disorder, Dyspnoea, Product dose omission issue, Product colour issue, |
||||
LITHIUM CARBONATE, |
||||
147 | 25134718 |
US |
76 | 2 |
Pneumonia pseudomonal, Systemic lupus erythematosus, Dyspnoea, Gastrooesophageal reflux disease, Decreased activity, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
148 | 25134905 |
CA |
44 | 1 |
Chest discomfort, Clostridium difficile infection, Drug interaction, Dyspnoea, Erythema, Fatigue, Flushing, Intentional product use issue, Off label use, |
||||
VANCOMYCIN HYDROCHLORIDE, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
149 | 25134929 |
US |
1 | |
Pneumonia, Nausea, Flushing, Dyspnoea, Oedema peripheral, Chest pain, Respiratory tract infection, Sputum discoloured, Headache, Constipation, Vomiting, Gastrooesophageal reflux disease, Weight decreased, Decreased appetite, Fatigue, Blood glucose abnormal, Diarrhoea, Memory impairment, Product dose omission issue, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TIRZEPATIDE, NINTEDANIB, NINTEDANIB, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, APIXABAN, SULFAMETHOXAZOLE AND TRIMETHOPRIM, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, PRIMIDONE, PREDNISONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, BUMETANIDE, INSULIN GLARGINE, OXYGEN, 0XYGEN, GABAPENTIN, EVOLOCUMAB, DRONEDARONE, |
||||
150 | 25134999 |
US |
64 | 2 |
Illness, Cough, Dyspnoea, |
||||
TOFACITINIB, |
||||
151 | 25135015 |
85 | ||
Haemoglobin decreased, Dyspnoea, |
||||
RUXOLITINIB, APIXABAN, APIXABAN, FISH OIL, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, SODIUM CHLORIDE, CYCLOSPORINE, |
||||
152 | 25135024 |
US |
69 | 1 |
Dyspnoea, Fatigue, |
||||
POMALIDOMIDE, |
||||
153 | 25135170 |
US |
82 | 2 |
Dyspnoea, |
||||
DUPILUMAB, |
||||
154 | 25135283 |
JP |
8 | 2 |
Immune-mediated adrenal insufficiency, Inappropriate schedule of product administration, Inappropriate schedule of product administration, Chest pain, Dyspnoea, Immune-mediated endocrinopathy, Immune-mediated hyperthyroidism, Physical deconditioning, Blood creatinine abnormal, |
||||
PEMBROLIZUMAB, |
||||
155 | 25135357 |
US |
1 | |
Dyspnoea, |
||||
IDURSULFASE, IDURSULFASE, |
||||
156 | 25135373 |
US |
83 | 1 |
Seizure, Hypoxia, Upper respiratory tract infection, Rhinitis, Pulmonary mass, Cough, Pain, Burning sensation, Decreased appetite, Dyspnoea, Pruritus, Insomnia, Diarrhoea, |
||||
DUPILUMAB, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
157 | 25135386 |
US |
2 | |
Anxiety, Dermatitis contact, Dyspnoea, Drug delivery system malfunction, |
||||
TREPROSTINIL, TREPROSTINIL, CETIRIZINE HYDROCHLORIDE, CHLORPHENIRAMINE MALEATE AND DEXTROMETHORPHAN HYDROBROMIDE, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROCHLORIDE, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MAGNESIUM, ERGOCALCIFEROL, ZOLPIDEM TARTRATE, TADALAFIL, CALCIUM, OXYGEN, 0XYGEN, SPIRONOLACTONE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FUROSEMIDE, AMBRISENTAN, |
||||
158 | 25135440 |
US |
81 | 2 |
Hypotension, Tachycardia, Anaemia, Haemoglobin decreased, Dyspnoea, Mobility decreased, Dyspnoea exertional, |
||||
RIOCIGUAT, RIOCIGUAT, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ALLOPURINOL, SILDENAFIL CITRATE, SILDENAFIL, ALBUTEROL SULFATE, BENZONATATE, OXYGEN, 0XYGEN, BUMETANIDE, SPIRONOLACTONE, TREPROSTINIL, GABAPENTIN, ERGOCALCIFEROL, |
||||
159 | 25135580 |
GB |
74 | 1 |
Dyspnoea, Influenza, |
||||
METHOTREXATE, METHOTREXATE SODIUM, |
||||
160 | 25135671 |
US |
75 | 2 |
Pyrexia, Productive cough, Dyspnoea, Pulmonary pain, Cough, |
||||
161 | 25135744 |
CA |
68 | 2 |
Death, Cytomegalovirus colitis, Fatigue, Dyspnoea, Cough, Back pain, Dysphagia, Hypoaesthesia oral, Dysgeusia, Headache, Nausea, Weight increased, |
||||
PALBOCICLIB, LETROZOLE, LETROZOLE TABLETS, FULVESTRANT, |
||||
162 | 25135790 |
US |
29 | 1 |
Neuropathy peripheral, Weight increased, Fatigue, Periorbital swelling, Arthralgia, Joint lock, Hypersomnia, Emotional disorder, Dysphemia, Peripheral swelling, Dizziness, Dyspnoea, Paraesthesia, Grip strength decreased, Blepharospasm, Muscular weakness, Chest pain, Drooling, Muscle twitching, Blood lactic acid increased, |
||||
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE, |
||||
163 | 25135828 |
CA |
78 | 2 |
Abdominal pain upper, Anaemia, Aspiration, Asthenia, Asthma, Blood calcium increased, Blood creatinine increased, Blood test abnormal, Bronchiectasis, Bronchopulmonary aspergillosis allergic, Constipation, Cough, Drug hypersensitivity, Drug ineffective, Dyspnoea, Fatigue, Gastrooesophageal reflux disease, General physical health deterioration, Haemoptysis, Headache, Hypoxia, Liver function test increased, Lower respiratory tract infection, Lung opacity, Musculoskeletal stiffness, Obstructive airways disorder, Oedema peripheral, Pain, Pleural effusion, Pleuritic pain, Pneumonia, Pulmonary fibrosis, Pulmonary mass, Pyrexia, Rales, Sputum discoloured, Total lung capacity decreased, Transaminases increased, Tremor, Upper respiratory tract infection, Wheezing, Product dose omission issue, |
||||
MONTELUKAST SODIUM, MONTELUKAST SODIUM, MONTELUKAST SODIUM, MONTELUKAST SODIUM, MOMETASONE FUROATE, MOMETASONE FUROATE, MOMETASONE FUROATE, MOMETASONE FUROATE, MONTELUKAST SODIUM, MONTELUKAST, MONTELUKAST SODIUM, MONTELUKAST, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, IPRATROPIUM BROMIDE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, CANDESARTAN, DEXLANSOPRAZOLE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, NITROGLYCERIN, NITROGLYCERIN, EFINACONAZOLE, EFINACONAZOLE, EFINACONAZOLE, LANSOPRAZOLE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, MOMETASONE, NITROGLYCERIN, MEPOLIZUMAB, MEPOLIZUMAB, OMALIZUMAB, OMALIZUMAB, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PRAMIPEXOLE, PRAMIPEXOLE, PRAMIPEXOLE, PRAMIPEXOLE, PREGABALIN, PREGABALIN, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, PYRILAMINE MALEATE, PYRILAMINE MALEATE, PYRILAMINE MALEATE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RISEDRONATE SODIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, SENNA LEAF, SENNOSIDES, SENNOSIDES, SENNOSIDES, STANDARDIZED SENNA CONCENTRATE, STANDARDIZED SENNA CONCENTRATE, STANDARDIZED SENNA CONCENTRATE, STANDARDIZED SENNA CONCENTRATE, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, SIMVASTATIN, LEVOTHYROXINE SODIUM, ALBUTEROL SULFATE, |
||||
164 | 25135856 |
US |
75 | 2 |
Dizziness, Dyspnoea, Malaise, |
||||
MEPOLIZUMAB, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, TIOTROPIUM BROMIDE, |
||||
165 | 25135914 |
US |
||
Dyspnoea, |
||||
166 | 25135999 |
DO |
2 | |
Metastases to bone, Pulmonary oedema, Dyspnoea, Metastases to lung, Metastases to liver, Metastases to spine, Metastases to central nervous system, Platelet count decreased, Haemoglobin decreased, Red blood cell count decreased, White blood cell count decreased, Hypokinesia, Back pain, |
||||
RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, |
||||
167 | 25136047 |
|||
Arthralgia, Localised infection, Dyspnoea, Abdominal discomfort, Neuropathy peripheral, Fatigue, Decreased appetite, Constipation, Diarrhoea, |
||||
CAPECITABINE, |
||||
168 | 25136102 |
CN |
16 | 1 |
Discomfort, Urticaria, Swelling, Dyspnoea, Pruritus, Hypertension, Drug hypersensitivity, Expired product administered, |
||||
169 | 25136122 |
IN |
64 | 2 |
Dyspnoea, Thrombosis, |
||||
IRINOTECAN HYDROCHLORIDE, METHYLPREDNISOLONE, APIXABAN, METOPROLOL TARTRATE, METOPROLOL, |
||||
170 | 25136126 |
US |
47 | 2 |
Dyspnoea, Hepatic enzyme increased, Cholelithiasis, |
||||
OZANIMOD HYDROCHLORIDE, |
||||
171 | 25136176 |
HU |
||
Blood glucose abnormal, Abnormal weight gain, Cardiac disorder, Bowel movement irregularity, Diarrhoea, Constipation, Asphyxia, Dyspnoea, |
||||
DAPAGLIFLOZIN, |
||||
172 | 25136201 |
US |
||
Chest discomfort, Disturbance in attention, Dizziness, Anxiety, Dizziness, Pain in extremity, Palpitations, Product substitution issue, Dyspnoea, |
||||
METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, ERGOCALCIFEROL, |
||||
173 | 25136214 |
US |
55 | 1 |
Dyspnoea, Off label use, |
||||
BUDESONIDE, ALLOPURINOL, DAPAGLIFLOZIN, EPLERENONE, FISH OIL, |
||||
174 | 25136398 |
CO |
60 | 2 |
Chest pain, Dyspnoea, Arteriospasm coronary, Urinary incontinence, Anal incontinence, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, ROSUVASTATIN, ROSUVASTATIN, |
||||
175 | 25136699 |
US |
83 | 1 |
Dyspnoea, |
||||
SUZETRIGINE, WARFARIN, |
||||
176 | 25136750 |
SE |
84 | 2 |
Cardiac arrest, Nasopharyngitis, Dyspnoea, Constipation, Off label use, Fluid intake reduced, |
||||
CEMIPLIMAB-RWLC, CALCIUM, |
||||
177 | 25136782 |
NL |
73 | 2 |
Palpitations, Dyspnoea, Atrial fibrillation, |
||||
EDOXABAN TOSYLATE, |
||||
178 | 25136790 |
GB |
51 | 1 |
Dyspnoea, Urinary hesitation, Pica, Oxygen saturation decreased, Micturition urgency, Haematocrit increased, Tunnel vision, Dehydration, Myalgia, Palpitations, Electrolyte imbalance, Loss of libido, Muscle spasms, Anhedonia, Erectile dysfunction, Dysuria, Hypoxia, Cognitive disorder, Rash, |
||||
EMPAGLIFLOZIN, TIRZEPATIDE, TESTOSTERONE, TESTOSTERONE,, CABERGOLINE, SOMATROPIN, INDAPAMIDE, LEVOTHYROXINE, |
||||
179 | 25136792 |
US |
1 | |
Loss of personal independence in daily activities, Sleep disorder due to a general medical condition, Dyspnoea, Chest discomfort, |
||||
DUPILUMAB, |
||||
180 | 25136804 |
US |
2 | |
Dyspnoea, Diarrhoea, Product dose omission issue, Expired product administered, |
||||
181 | 25136836 |
GB |
||
Dyspnoea, |
||||
TIRZEPATIDE, |
||||
182 | 25136895 |
GB |
68 | 2 |
Chest discomfort, Choking, Dyspnoea, |
||||
LATANOPROST, TIMOLOL, |
||||
183 | 25136925 |
US |
71 | 1 |
Prostate cancer, Incorrect product administration duration, Dyspnoea, Fatigue, Gait disturbance, |
||||
PEMBROLIZUMAB, |
||||
184 | 25136945 |
US |
67 | 2 |
Dyspnoea, Headache, Rash, |
||||
ALENDRONATE SODIUM, AMLODIPINE BESYLATE, ALLOPURINOL, ERGOCALCIFEROL, LOSARTAN, PSYLLIUM HUSK, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, SELEXIPAG, TADALAFIL, CARVEDILOL, FAMOTIDINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CETIRIZINE HYDROCHLORIDE, |
||||
185 | 25136961 |
GB |
27 | 2 |
Dyspnoea, Wheezing, Urticaria, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
186 | 25136993 |
US |
2 | |
Suicidal ideation, Dyspnoea, Blood glucose fluctuation, Nausea, Vomiting, Generalised oedema, Injection site rash, Injection site pain, Injection site swelling, Rash, |
||||
INSULIN LISPRO, INSULIN DETEMIR, |
||||
187 | 25140833 |
60 | 1 | |
Peripheral swelling, Blister, Oral mucosal blistering, Dyspnoea, |
||||
UPADACITINIB, |
||||
188 | 25126282 |
US |
49 | 2 |
Dyspnoea, Device use error, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, FOLIC ACID, LOPERAMIDE HYDROCHLORIDE, MACITENTAN, TORSEMIDE, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, PREDNISONE, METHOTREXATE, METHOTREXATE SODIUM, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, SPIRONOLACTONE, OMEPRAZOLE MAGNESIUM, |
||||
189 | 25126293 |
US |
88 | 2 |
Feeling abnormal, Oxygen saturation decreased, Heart rate decreased, Asthenia, Dyspnoea, Blood glucose increased, Headache, Injection site bruising, Nausea, |
||||
EVOLOCUMAB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
190 | 25126337 |
CA |
69 | |
Skin discolouration, Dyspnoea exertional, Pallor, Dyspnoea, |
||||
RAVULIZUMAB, RAVULIZUMAB, RAVULIZUMAB, HUMAN IMMUNOGLOBULIN G, |
||||
191 | 25126398 |
US |
85 | |
Dyspnoea, |
||||
APIXABAN, |
||||
192 | 25126401 |
US |
2 | |
Dyspnoea, |
||||
TOCILIZUMAB, MONTELUKAST SODIUM, MONTELUKAST, |
||||
193 | 25126403 |
US |
72 | 2 |
Influenza, Thrombosis, Pulmonary thrombosis, Dyspnoea, |
||||
LENALIDOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), NALOXONE, OXYCODONE, GABAPENTIN, ACYCLOVIR, ALLOPURINOL, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, SULFAMETHOXAZOLE AND TRIMETHOPRIM, OLANZAPINE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, ENOXAPARIN SODIUM, METHOCARBAMOL, METHOCARBAMOL TABLETS, FLUTICASONE PROPIONATE, TRIPROLIDINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
194 | 25126418 |
US |
73 | 1 |
Fluid retention, Dyspnoea, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, MELATONIN, TADALAFIL, ACYCLOVIR, TESTOSTERONE CYPIONATE, FOLIC ACID, DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, SACUBITRIL AND VALSARTAN, PREGABALIN, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, BUPROPION HYDROCHLORIDE, ERGOCALCIFEROL, CABOTEGRAVIR AND RILPIVIRINE, SPIRONOLACTONE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, FLUOROURACIL, PRAMIPEXOLE DIHYDROCHLORIDE, FEBUXOSTAT, FEBUXOSTAT TABLETS 40 MG, FEBUXOSTAT TABLETS 80 MG, TORSEMIDE, AMBRISENTAN, VITAMIN C, |
||||
195 | 25126466 |
US |
2 | |
Cough, Feeling abnormal, Rhinorrhoea, Dyspnoea, Tremor, Dyspnoea exertional, Dyspepsia, Abdominal pain upper, Hypersomnia, Headache, Pain in jaw, Product dose omission in error, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, NINTEDANIB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, QUETIAPINE, VALBENAZINE, AMLODIPINE BESYLATE, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, FAMOTIDINE, DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, DIVALPROEX SODIUM, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ALBUTEROL SULFATE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, OXYGEN, 0XYGEN, OXYGEN, 0XYGEN, HYDROCHLOROTHIAZIDE, |
||||
196 | 25126467 |
US |
2 | |
Headache, Dizziness, Hypertension, Dyspnoea, Dyspnoea exertional, Inappropriate schedule of product administration, Product dose omission issue, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, NINTEDANIB, NINTEDANIB, SILDENAFIL CITRATE, SILDENAFIL, OXYGEN, 0XYGEN, OXYGEN, 0XYGEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
197 | 25126508 |
CA |
2 | |
Urinary tract infection, Dyspnoea, Emotional distress, Immunosuppression, Ophthalmic herpes zoster, Pulmonary mass, Mitral valve incompetence, Fatigue, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, AZATHIOPRINE, EFGARTIGIMOD ALFA, PREDNISONE, CALCIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DEXLANSOPRAZOLE, ALENDRONATE SODIUM, HYDROXYUREA, MAGNESIUM OXIDE, PYRIDOSTIGMINE BROMIDE, METOPROLOL TARTRATE, METOPROLOL, SULFASALAZINE, PYRIDOSTIGMINE BROMIDE, EFGARTIGIMOD ALFA, |
||||
198 | 25126557 |
CA |
40 | 2 |
Dyspnoea, Nausea, Aphasia, |
||||
FERRIC DERISOMALTOSE, |
||||
199 | 25126666 |
US |
||
Dyspnoea, Intentional product use issue, Product dose omission issue, Wrong technique in product usage process, Device malfunction, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
200 | 25126675 |
US |
||
Dyspnoea, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28